CIK 0001088856
- Large accelerated filer
CORCEPT THERAPEUTICS INC
Sign in to watch- Ticker
- CORT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 770487658
- Phone
- +1 650-688-8803
- Business address
- 101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
- 4/A Open-market sale Chief Development Officer sold 4,500 shares at $80.90 ($364,070)
- 4 Open-market sale Chief Development Officer sold 4,500 shares at $80.90 ($364,070)
- 4 Planned sale Chief Development Officer sold 20,000 shares at an average $75.36 ($1,507,122)
- 4 Planned sale See Remarks sold 5,000 shares at $73.65 ($368,245)
- 4 Planned sale Chief Executive Officer sold 40,000 shares at an average $74.58 ($2,983,119)
- 4 Planned sale See Remarks sold 20,000 shares at $73.99 ($1,479,816)
- 4 Planned sale Director sold 2,200 shares at $87.54 ($192,588)
- 4 Planned sale Chief Development Officer sold 20,000 shares at $89.94 ($1,798,782)
- 4 Planned sale Chief Executive Officer sold 40,000 shares at an average $85.08 ($3,403,253)
- 4 Planned sale See Remarks sold 5,000 shares at an average $84.75 ($423,766)
- 4 Planned sale See Remarks sold 20,000 shares at an average $85.06 ($1,701,232)
- 4 Gift Chief Development Officer gave 200 shares (gift)
- 4 Gift Director gave 7,393 shares (gift)
- 4 Planned sale Director sold 2,200 shares at $72.45 ($159,390)
- 4 Shares withheld for taxes Director gave up 3,607 shares (to pay taxes)
- 4 Planned sale Chief Development Officer sold 20,000 shares at an average $70.49 ($1,409,848)
- 4 Planned sale See Remarks sold 5,000 shares at an average $70.25 ($351,247)
- 4 Planned sale See Remarks sold 20,000 shares at an average $70.49 ($1,409,828)
- 4 Planned sale Chief Executive Officer sold 40,000 shares at an average $70.53 ($2,821,033)
- 4 Grant or award Chief Financial Officer acquired 400 shares (grant or award)
Page 6 of 60 · 1,196 filings